Cardiometabolic dysregulation, depression and cognitive functioning: longitudinal associations in the CLSA
Description: Deterioration of cognitive function can affect an individual's overall health and well-being, including self-care activities, as well as the ability to effectively manage medical conditions and to participate actively in society. Cardiometabolic factors like obesity, high blood pressure, and diabetes might affect cognitive function. There is evidence linking depression with poor cognitive function. Depression in combination with metabolic problems might increase the risk of poor cognitive function. Using data from the Canadian Longitudinal Study on Aging, the objective of the proposed study is to investigate the associations between metabolic problems, depression, depression severity and decline in cognitive function. This project will provide important information about the interaction of depression cardiometabolic dysregulation on cognitive decline. The results might inform the development of strategies for prevention at the individual level and might have the potential to contribute to the development of tailored treatments for depression.
Amount: CA$77,300
Funding type: research
Funder scheme: Catalyst Grant: Analysis of Canadian Longitudinal Study in Aging (CLSA) Data
Start date: 2020-03-01
End date: 2021-02-28
Investigator: Norbert Schmitz
Institution: CIUSSS de l'Ouest-de-l'Ile-de-Montreal-Douglas Hospital
Funded outputs count: 0
Funder award ID: 170402_1
OpenAlex ID: G4007501928